Cart
sales@molnova.com
Elsulfavirine
CAS No. 868046-19-9
Elsulfavirine( Elpida | VM-1500 )
Catalog No. M24876 CAS No. 868046-19-9
Elsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 211 | In Stock |
|
| 5MG | 150 | In Stock |
|
| 10MG | 242 | In Stock |
|
| 25MG | 487 | In Stock |
|
| 50MG | 714 | In Stock |
|
| 100MG | 1004 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElsulfavirine
-
NoteResearch use only, not for human use.
-
Brief DescriptionElsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
-
DescriptionElsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
-
In Vitro——
-
In Vivo——
-
SynonymsElpida | VM-1500
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number868046-19-9
-
Formula Weight629.28
-
Molecular FormulaC24H17BrCl2FN3O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:60 mg/mL?(95.35 mM;?Need ultrasonic)
-
SMILESCCC(NS(c(cc1)cc(Cl)c1NC(Cc(ccc(Br)c1Oc2cc(Cl)cc(C#N)c2)c1F)=O)(=O)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rai MA, et al. Emerging reverse transcriptase inhibitors for HIV-1 infection. Expert Opin Emerg Drugs. 2018 Jun;23(2):149-157.
molnova catalog
related products
-
NBD-557
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.
-
(Rac)-Telinavir
(Rac)-Telinavir shows anti-HIV activity.
-
Pitstop2
Pitstop2 is a selective inhibitor of amphiphysin association of clathrin terminal domain with an IC50 value of 12 μM. Pitstop2 acutely interferes with receptor-mediated endocytosis, entry of HIV, and synaptic vesicle recycling.
